# How to Connect

Much like an ecosystem, the life sciences community is connected through a collective drive to innovate. Our partnering environment is built on trust and scientific collaboration. We focus on co-creating, accelerating scientific breakthroughs and delivering solutions for patients.

Whether you’re a biotech innovator or academic researcher, let’s start a conversation about partnering!

## Our team

We work across the globe reaching partners from North America, Europe, Asia and more. Every member of our team has experience in dedicated [disease areas](/content/science-innovation/human-health-innovation/science-focus/index.html) or technology spaces. We’re pursuing new partnerships and evolving current collaborations to broaden our capabilities and explore new therapeutic areas and modalities.

**Interested in partnering? Let's connect!** Fill out our contact form and share a brief non-confidential project summary with us. We’ll typically respond to you in under seven business days. Please note that this communication is not intended for adverse event reporting.

[Complete the contact form](/content/partnering/human-health-partnering/how-connect/contact-boehringers-business-development-and-licensing/index.html)

## Find a team member

### ### Cardiovascular-renal-metabolic diseases

|     |     |
| --- | --- |
|  | Andrew Whittle, PhD<br>Head of CRM business development<br>Boston, MA (USA)<br>Partnership focus: Kidney diseases and obesity |

|     |     |
| --- | --- |
|  | Annika Baur, PhD<br>Biberach, Germany<br>Partnership focus: Liver disease |

|     |     |
| --- | --- |
|  | Robert Augustin, PhD<br>Biberach, Germany<br>Partnership focus: Stroke and cardiovascular disease |

### ### Eye health

|     |     |
| --- | --- |
|  | Peter Benz, PhD<br>Head of eye health business development<br>Biberach, Germany<br>Partnership focus: Diseases of the back of the eye |

### ### Immunology and respiratory diseases

|     |     |
| --- | --- |
|  | Fei Shen, PhD<br>Head of global inflammation business development<br>Boston, MA (USA)<br>Partnership focus: Pulmonary fibrosis, inflammatory bowel disease, systemic lupus erythematosus and rheumatoid arthritis |

|     |     |
| --- | --- |
|  | David Blair, PhD<br>Ridgefield, Connecticut (USA)<br>Partnership focus: Immunological disorders |

|     |     |
| --- | --- |
|  | Christian Kuttruff, PhD<br>Biberach, Germany<br>Partnership focus: Respiratory diseases (idiopathic pulmonary fibrosis, progressive pulmonary fibrosis) |

|     |     |
| --- | --- |
|  | Marcio Lasaro, PhD<br>Ridgefield, Connecticut (USA)<br>Partnership focus: Immunological disorders |

### ### Mental health and neuroscience

|     |     |
| --- | --- |
|  | René Fürtig, PhD<br>Head of mental health business development<br>Ingelheim, Germany<br>Partnership focus: Psychiatric disorders, Nociplastic pain |

|     |     |
| --- | --- |
|  | Radoslaw Lipinski, DPhil<br>Biberach, Germany  <br>Partnership focus: Neurodegeration, Psychiatric disorders |

### ### Oncology

|     |     |
| --- | --- |
|  | Oliver Kast, PharmD<br>Head of oncology business development<br>Ingelheim, Germany<br>Partnership focus: Solid tumor therapies, targeted therapeutics, immuno-oncology |

|     |     |
| --- | --- |
|  | Stephanie Glaser, PhD<br>Ingelheim, Germany  <br>Partnership focus: Antibody drug conjugates, T cell engagers |

|     |     |
| --- | --- |
|  | Anto Impagnatiello, PhD<br>Vienna, Austria<br>Partnership focus: Antibody drug conjugates, immunogenic cell death |

|     |     |
| --- | --- |
|  | Sokol Haxhinasto, PhD<br>Ridgefield, Connecticut (USA)<br>Partnership focus: Immuno-oncology, T cell engagers |

### ### Emerging science

|     |     |
| --- | --- |
|  | Bernd Nosse, PhD<br>Head of emerging areas<br>Biberach, Germany  <br>Partnership focus: Adeno-associated virus gene therapies, Neurodegeneration |

### ### Technologies

|     |     |
| --- | --- |
|  | Radoslaw Lipinski, DPhil<br>Biberach, Germany  <br>Partnership focus: Small molecule technology |

|     |     |
| --- | --- |
|  | Marcio Lasaro, PhD<br>Ridgefield, Connecticut (USA)<br>Partnership focus: Antibody technology |

|     |     |
| --- | --- |
|  | Gang Wang, PhD<br>Ridgefield, Connecticut (USA)<br>Partnership focus: Antibody technology |

|     |     |
| --- | --- |
|  | Christian Kuttruff, PhD<br>Biberach, Germany<br>Partnership focus: Small molecule technology |

|     |     |
| --- | --- |
|  | Alessandra Barazza, PhD<br>Ridgefield, Connecticut (USA)<br>Partnership focus: Antibody technology |

### ### Cross-therapeutic area partnering in Asia

|     |     |
| --- | --- |
|  | June Hahn, PhD<br>Seoul, Republic of Korea |

Learn more about our partnering interests and other business opportunities across our company.

[Learn more](/content/partnering/human-health-partnering/partnering-interests "Partnering interests"/index.html)

### Partnering interests

Read about the areas where we’re looking to partner.

[Learn more](/content/partnering/human-health-partnering/partnering-interests "Learn more"/index.html)

### Independent funding

Explore opportunities with the Boehringer Ingelheim Venture Fund.

[Learn more](/content/disclaimer/external?path=https%3A%2F%2Fwww.boehringer-ingelheim-venture.com%2F "Learn more"/index.html)

### Beyond partnering

Business development isn’t the only way to make a difference together.

[Learn more](/content/partnering/collaborative-opportunities "Learn more"/index.html)

Stay up to date on our most recent partnerships and research collaborations.

[Latest news](/content/media-stories/press-releases?department%5B0%5D=2 "Latest news"/index.html)